# Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy

> **NCT02101008** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 12 (actual)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** disulfiram and chelated zinc

## Key facts

- **NCT ID:** NCT02101008
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-02
- **Final completion:** 2013-11-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101008, "Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02101008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*